AP
GILD icon

Americana Partners’s Gilead Sciences GILD Stock Holding History

Americana Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,463
Closed -$384K – 491
2025
Q3 		$384K Buy
+3,463
New +$394K 0.01% 344
2022
Q3 		– Sell
-3,629
Closed -$224K – 252
2022
Q2 		$224K Buy
+3,629
New +$225K 0.04% 220
2022
Q1 		– Sell
-3,693
Closed -$268K – 250
2021
Q4 		$268K Sell
3,693
-1,391
-27% -$95.8K 0.05% 218
2021
Q3 		$355K Buy
+5,084
New +$357K 0.09% 167

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Americana Partners's GILD Position: Q4 2025 in Review

Americana Partners sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,463 shares — an estimated $384K sold.

Americana Partners first reported a position in GILD in Q3 2021 and held it in 4 quarters. The position peaked at $384K in Q3 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Americana Partners reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Americana Partners sold 3,463 Gilead Sciences shares in Q4 2025, an estimated $384K.
  • Americana Partners first reported a position in Gilead Sciences in Q3 2021 and held it in 4 quarters.
  • Americana Partners's Gilead Sciences position peaked at $384K in Q3 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Americana Partners's 13F filing for Q4 2025, filed 6 Feb 2026.